Compliance with anticonvulsant therapy in a hospital clinic and in the community.
暂无分享,去创建一个
[1] F. Buchthal,et al. Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. , 1960, Archives of neurology.
[2] J. Haynes,et al. Some causes of ineffectiveness of diphenylhydantoin. , 1966, Archives of neurology.
[3] J. MacGee. Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography. , 1970, Analytical chemistry.
[4] A. Handley,et al. Supervision of Epileptic Patients Taking Phenytoin , 1970, British medical journal.
[5] M. Eadie,et al. Plasma diphenylhydantoin levels in Australian adults. , 1974, Australian and New Zealand journal of medicine.
[6] J. M. Sutherland,et al. Diphenylhydantoin concentrations in saliva. , 1974, Archives of neurology.
[7] F. Williams,et al. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital , 1974, Clinical pharmacology and therapeutics.
[8] L. O'Tuama,et al. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay , 1975, Clinical pharmacology and therapeutics.
[9] E. Critchley,et al. Control of epilepsy with a single daily dose of phenytoin sodium. , 1975, British journal of clinical pharmacology.
[10] E. Reynolds,et al. ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSY , 1976, The Lancet.
[11] G. Scambler,et al. HOW DOCTORS DEAL WITH EPILEPSY , 1977, The Lancet.
[12] C. Dollery,et al. Drug concentration in saliva , 1978, Clinical pharmacology and therapeutics.